Confidential company overview · 2026

Infrastructure-ready. Carbon-negative.
Revenue-positive.

OREVO Fuels converts municipal wastewater sludge into fossil-identical renewable diesel and SAF using Corazyme™, a proprietary enzymatic platform. No new infrastructure. No combustion. No agricultural feedstocks. Deployable within 6 months of pilot agreement. Bench-validated and raising a $10M Series A.

The Corazyme™ process
01 — Input

Wastewater sludge

Municipal and industrial facilities generate sludge continuously. Already collected on-site. No feedstock logistics, no procurement cost, no agricultural land use. The input is the liability cities already pay to remove.

02 — Conversion

Enzymatic platform

Corazyme™ uses a proprietary enzyme system to convert biogenic carbon at ambient temperature and pressure. No gasification, no combustion, no high-energy input required. Modular unit retrofits directly to existing wastewater infrastructure.

03 — Output

Fossil-identical fuel

Specification-compliant renewable diesel for immediate sale or on-site use. SAF-compatible molecules follow ASTM D7566 certification pathway. Carbon credits generated per gallon from day one of operation.

Revenue sequencing
First revenue — immediate

Renewable Diesel

  • Drop-in compatible with all ground, marine, and fleet applications
  • No ASTM certification required — immediate offtake potential
  • Municipal fleets, Army installations, logistics hubs as first buyers
  • Revenue from first day of commercial module operation
  • $8.78/gal market price · $0.51–$1.70/gal production cost
Development pathway — premium upside

Sustainable Aviation Fuel (SAF)

  • Corazyme™ produces SAF-compatible molecules from the same process
  • ASTM D7566 certification pathway in progress
  • Airline offtake agreements and SAF mandates create strong demand
  • 45Z credit applies to SAF at higher per-gallon value than diesel
  • Premium margins unlock at qualification — same infrastructure
Unit economics — commercial module

Example based on ~300K population facility (Minneapolis MET Council scale)

Annual fuel output505,890 gallons
Production cost / gallon$0.51 — $1.70
Market price / gallon$8.78
Annual revenue$4.4M
Gross margin~94%
With 45Z uplift / gallon$10.30 — $10.50
5-module revenue$22.2M
5-module gross profit$20.8M

Fuel sales only. Additional revenue lines (licensing, enzyme supply, carbon credits) materially increase total site value. Larger systems serving 3M+ population support ~10x output.

Core value proposition
Fossil-identical drop-in output

Diesel, SAF, and gasoline compatible with all existing pipelines, refineries, and engines. No downstream modifications.

No new infrastructure required

Modular unit attaches to existing treatment facilities. Low CapEx. Rapid installation. Minimal site disruption.

Ambient conditions only

No combustion, no gasification, no high-energy inputs. Enzymatic process runs at ambient temperature and pressure.

Verified carbon credits

CI profile meets 45Z threshold. Drives materially higher per-module EBITDA and strengthens strategic buyer economics.

Domestically sourced feedstock

Every U.S. city generates sludge continuously. No foreign supply chain exposure. Stable, low-cost, high-volume input.

Non-food, non-agricultural

No food-grade inputs, no farmland use, no synthetic fuel dependency. Real waste, not competing land or crop resources.

Ideal applications

Municipal wastewater utilities

Industrial operators (food & beverage)

Airports & on-site fuel demand

U.S. military installations

State decarbonization programs

Series A raise
$10M
Pre-money valuation
$90M
Investor ownership
10%
Return multiple
6.9x — 21.5x
Runway
2.5 — 3 yrs
Company overview

Business description

OREVO is a biotech infrastructure company that transforms municipal wastewater into fossil-identical fuels via Corazyme™. The platform integrates into existing infrastructure to produce drop-in fuel without new construction, enabling decarbonization without disruption.

The product

A modular, retrofittable enzymatic system that converts wastewater sludge into fossil-identical fuels. Includes proprietary conversion technology, consumable enzymes, licensing, and performance tracking for fuel generation and carbon credit creation.

Competitive edge

Most alternatives require synthetic inputs or capital-intensive redesign. Corazyme™ operates at ambient conditions with minimal inputs, delivering low-cost, low-carbon fuels from systems already in place. No food-grade feedstocks.

Business model

Revenue through fuel sales, technology licensing, enzyme supply, and carbon credit monetization. Each stream scales independently while reinforcing platform value. Fuel offtake agreements secure recurring EBITDA from day one of operation.

Competitive landscape
Company Modular deployment No combustion Non-food feedstock No new construction Drop-in compatible Immediate revenue
Corazyme™ / OREVO Fuels
LanzaJet
Fulcrum Bioenergy
Gevo
Traditional biofuel
Market rollout — stage status
Stage 1
Bench-scale complete

Enzymatic platform validated. IP secured. Yield and cost profile confirmed. Patent application submitted.

Complete
Stage 2
Pilot in progress

Active conversations in Minneapolis, Vacaville, and Seattle. MOUs signed. DOE SBIR and ITV grants submitted.

In progress
Stage 3
Commercial prep

First commercial module build funded by Series A. Site integration, fuel qualification, first offtake agreements.

Series A
Stage 4
Scaled rollout

35 modules in 7 years. $154M revenue, $86M EBITDA. Strategic exit to energy major at $688M–$2.15B.

Year 7
The team
Robert Roscow

Robert Roscow

Co-Founder & CEO

Molecular biologist with deep experience in enzymatic system engineering and industrial biomanufacturing. Led R&D teams, secured IP across biotech and plant genetics, and contributed to over $450M in successful exits. Drives technical direction and Corazyme™ commercial readiness.

Daniel Falk

Daniel Falk

Co-Founder & CBO

Business development leader with background in regulated infrastructure and multi-year commercial partnerships. Compliance expert for large human services systems and recurring contract negotiation track record for multi-site business models. Leads commercialization and buyer engagement.

Go-to-market & distribution

Strategy

Pilot validation and early revenue through fuel offtake, licensing, and carbon market entry. IP-protected process and modular format reduce friction, allowing scale without infrastructure expansion.

Sales & distribution

Pilot launches with municipal or industrial partner, supporting validation and case study development. Future sales driven through direct partnerships and public funding opportunities including SBIR and DOE grants.

Customer segments

Initial customers include fuel buyers, airports, wastewater operators, and large energy consumers. Platform designed to scale into logistics, utilities, and government markets including U.S. military installations.

Exit landscape

Energy majors deploying billions into SAF and low-carbon fuels. Chevron ($3B+), BP ($4B+), Shell ($10B+), ExxonMobil ($17B+). Corazyme™ aligns directly with acquisition theses around feedstock, CI, and scalability.

Ready to discuss
Book a call with the founders
team@orevofuels.com
orevofuels.com/invest